Bandages become obsolete!Arch Thrspeutics,Inc.(OTCB:ARTH)has a peptide gel that seals bleeding (AC5) . Ian Cooper mailed a recommendation to me.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I suspect Ian Cooper was paid to recommend it, then. This is a recent reverse merger company that doesn’t appear to actually have a business (yet, at least) — haven’t looked closely enough to be positive, but it’s very likely a pump and dump stock promotion scam.
I had a couple month old opportunity letter I opened yesterday with the ARTH info.
I looked at the info since I have had many bleedy experiences in my life (and think nano tech seems a cool future thing-will it make money in my lifetime – the scientists better hurry) .
I still like the first superglue which was blue, my Dad brought home after WW2. It sealed up a table saw slit like magic. Anyway I looked at the website and at the scientist. He has many similar (nano) project / innovations and recently is talking to the scientific community, it seems. The company (which purchased a company that never made any money to get the exchange listing) states they are in animal testing, but there is no indication of clinical trials, or any real info about a product for actual use. Nor are there any projections or any info that may mean tangible earnings, those are conveniently missing.
OK so I am not going back to the websites to get the particulars specifically referenced above (lazy-sure), but it only took me a half hour or so to click everywhere on the site and check finance.yahoo for recent news and earnings. The black ‘Early Alert’ card says a great buy below $2. The history has 1 spike to about $6 and now is about $.5. Wait for it to go to fractional cents before you buy (just a good general rule) if you want to wait ten years or so for your speculation $ to potentially grow. The finance yahoo writers have a good take on it – I would mangle to try to reiterate. It’s a short read, probably shorter than this post!